Obesity in patients with acute lymphoblastic leukemia in childhood

Lorenzo Iughetti, Patrizia Bruzzi, Barbara Predieri, Paolo Paolucci, Lorenzo Iughetti, Patrizia Bruzzi, Barbara Predieri, Paolo Paolucci

Abstract

Acute lymphoblastic leukemia is the most common malignancy in childhood. Continuous progress in risk-adapted treatment for childhood acute lymphoblastic leukemia has secured 5-year event-free survival rates of approximately 80% and 8-year survival rates approaching 90%. Almost 75% of survivors, however, have a chronic health condition negatively impacting on cardiovascular morbidity and mortality. Obesity can be considered one of the most important health chronic conditions in the general population, with an increasing incidence in patients treated for childhood cancers and especially in acute lymphoblastic leukemia survivors who are, at the same time, more at risk of experiencing precocious cardiovascular and metabolic co-morbidities. The hypothalamic-pituitary axis damage secondary to cancer therapies (cranial irradiation and chemotherapy) or to primary tumor together with lifestyle modifications and genetic factors could affect long-term outcomes. Nevertheless, the etiology of obesity in acute lymphoblastic leukemia is not yet fully understood. The present review has the aim of summarizing the published data and examining the most accepted mechanisms and main predisposing factors related to weight gain in this particular population.

References

    1. Pui CH Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030–1043. doi: 10.1016/S0140-6736(08)60457-2.
    1. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL. Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82. doi: 10.1056/NEJMsa060185.
    1. Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL) Eur J Cancer Care. 2005;14(1):53–62. doi: 10.1111/j.1365-2354.2005.00513.x.
    1. Dalmasso P, Pastore G, Zuccolo L, Maule MM, Pearce N, Merletti F, Magnani C. Temporal trends in the incidence of childhood leukemia, lymphomas and solid tumors in north-west Italy, 1967-2001. A report of the Childhood Cancer Registry of Piedmont. Haematologica. 2005;90:1197–1204.
    1. Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O'Leary M, Smith FO, Reaman GH. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28:2625–2634. doi: 10.1200/JCO.2009.27.0421.
    1. Odame I, Reilly JJ, Gibson BES, Donaldson MDC. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia. Arch Dis Child. 1994;71:147–149. doi: 10.1136/adc.71.2.147.
    1. Van Dongen-Melman JE, Hokken-Koelaga AC, Hahlen K, De Groot A, Tromp CG, Egeler RM. Obesity after successful treatment of ALL in childhood. Pediatr Res. 1995;38:86–90. doi: 10.1203/00006450-199507000-00015.
    1. Arguelles B, Barrios V, Buno M, Madero L, Argente J. Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin levels in children with acute lymphoblastic leukemia: a prospective study. Eur J Endocrinol. 2000;143:243–250. doi: 10.1530/eje.0.1430243.
    1. Withycombe JS, Post-White JE, Meza JL, Hawks RG, Smith LM, Sacks N, Seibel NL. Weight patterns in children with higher risk ALL: a report from the children's oncology group (COG) for CCG 1961. Pediatr Blood Cancer. 2009;53:1249–1254. doi: 10.1002/pbc.22237.
    1. Baillargeon J, Langevin AM, Lewis M, Grady JJ, Thomas PJ, Mullins J, Estrada J, Pitney A, Sacks N, Pollock BH. Therapy-related changes in body size in Hispanic children with acute lymphoblastic leukemia. Cancer. 2005;103:1725–1729. doi: 10.1002/cncr.20948.
    1. Didi M, Didcock E, Davies HA, Ogilvy-Stuart AL, Wales JK, Shalet SM. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr. 1995;127(1):63–67. doi: 10.1016/S0022-3476(95)70258-X.
    1. Zee P, Chen CH. Prevalence of obesity in children after therapy for acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 1986;8:294–299. doi: 10.1097/00043426-198624000-00005.
    1. Sainsbury CPQ, Newcombe RG, Hughes IA. Weight gain and height velocity during prolonged first remission from ALL. Arch Dis Child. 1985;60:832–836. doi: 10.1136/adc.60.9.832.
    1. Brouwer CAJ, Gietema JA, Kamps WA, de Vries EGE, Postma A. Changes in body composition after childhood cancer treatment: impact on future health status-a review. Crit Rev Oncol Hematol. 2007;63:32–46. doi: 10.1016/j.critrevonc.2007.01.007.
    1. Jenney ME, Faragher EB, Jones PH, Woodcock A. Lung function and exercise capacity in survivors of childhood leukaemia. Med Pediatr Oncol. 1995;24(4):222–30. doi: 10.1002/mpo.2950240403.
    1. Ventham JC, Reilly JJ. Childhood leukemia: a model of pre-obesity. Proc Nutr Soc. 1999;58:277–281. doi: 10.1017/S0029665199000385.
    1. Warner JT, Evans WD, Webb DK, Gregory JW. Body composition of long-term survivors of acute lymphoblastic leukaemia. Med Pediatr Oncol. 2002;38:165–72. doi: 10.1002/mpo.1304.
    1. Marinovic D, Dorgeret S, Lescoeur B, Alberti C, Noel M, Czernichow P, Sebag G, Vilmer E, Leger J. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study. Pediatrics. 2005;116:e102–8. doi: 10.1542/peds.2004-1838.
    1. Bond SA, Han AM, Wootton SA, Kohler JA. Energy intake and basal metabolic rate during maintenance chemotherapy. Arch Dis Child. 1992;67(2):229–32. doi: 10.1136/adc.67.2.229.
    1. Delbecque-Boussard L, Gottrand F, Ategbo S, Nelken B, Mazingue F, Vic P, Farriaux JP, Turck D. Nutritional status of children with acute lymphoblastic leukemia: a longitudinal study. Am J Clin Nutr. 1997;65(1):95–100.
    1. Halton JM, Atkinson SA, Barr RD. Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia. Int J Cancer. 1998;11:81–84.
    1. Jansen H, Postma A, Stolk RP, Kamps WA. Acute lymphoblastic leukemia and obesity: increased energy intake or decreased physical activity? Support Care Cancer. 2009;17:103–106. doi: 10.1007/s00520-008-0531-0.
    1. Craig F, Leiper AD, Stanhope R, Brain C, Meller ST, Nussey SS. Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index. Arch Dis Child. 1999;81:500–504. doi: 10.1136/adc.81.6.500.
    1. Adan L, Trivin C, Sainte-Rose C, Zucker JM, Hartmann O, Brauner R. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J Clin Endocrinol Metab. 2001;86:5245–5251. doi: 10.1210/jc.86.11.5245.
    1. Leiper AD, Stanhope R, Kitching P, Chessells JM. Precocius and premature puberty associated with treatment of acute lymphoblastic leukemia. Arch Dis Child. 1987;62:1107–12. doi: 10.1136/adc.62.11.1107.
    1. Cicognani A, Cacciari E, Rosito P. Longitudinal growth and final height in long-term survivors of childhood leukemia. Eur J Pediatr. 1994;153:726–30. doi: 10.1007/BF01954488.
    1. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, Vik TA, Inskip PD, Robison LL. Childhood Cancer Survivor Study. Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2003;21:1359–1365. doi: 10.1200/JCO.2003.06.131.
    1. Sklar CA, Mertens AC, Walter A, Mitchell D, Nesbit ME, O'Leary M, Hutchinson R, Meadows AT, Robison LL. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol. 2000;35:91–5. doi: 10.1002/1096-911X(200008)35:2<91::AID-MPO1>;2-G.
    1. Link K, Moell C, Garwicz S, Cavallin-Stahl E, Bjork J, Thilen U, Ahren B, Erfurth EM. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab. 2004;89:5003–5012. doi: 10.1210/jc.2004-0126.
    1. Nysom K, Holm K, Michaelsen KF, Hertz H, Muller J, Molgaard C. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab. 1999;84:4591–4596. doi: 10.1210/jc.84.12.4591.
    1. Jarfelt M, Lannering B, Bosaeus I, Johannsson G, Bjarnason R. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol. 2005;153:81–9. doi: 10.1530/eje.1.01931.
    1. Murphy AJ, Wells JCK, Williams JE, Fewtrell MS, Davies PS, Webb DK. Body composition in children in remission from acute lymphoblastic leukemia. Am J Clin Nutr. 2006;83:70–74.
    1. Vaisman N, Stallings VA, Chan H, Weitzman SS, Clarke R, Pencharz PB. Effect of chemotherapy on the energy and protein metabolism of children near the end of treatment for acute lymphoblastic leukemia. Am J Clin Nutr. 1993;57(5):679–84.
    1. Birkebaek NH, Clausen N. Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia. Arch Dis Child. 1998;79:161–164. doi: 10.1136/adc.79.2.161.
    1. Ahmed SF, Wallace WH, Kelnar CJ. An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukemia. Horm Res. 1997;48(4):178–183. doi: 10.1159/000185510.
    1. Ventham J, Reilly JJ, Dinaldson MDC, Gibson BES. Pattern and timing of weight gain in Scottish children treated for acute lymphoblastic leukemia. Proceedings of the Nutrition Society. 1998;57:334.
    1. Garmey EG, Liu Q, Sklar CA, Meacham LR, Mertens AC, Stovall MA, Yasui Y, Robinson LL, Oeffinger KC. Longitudinal changes in obesity and body mass index among adults survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26:4639–4645. doi: 10.1200/JCO.2008.16.3527.
    1. Razzouk BI, Rose RS, Hongeng S, Wallace D, Smeltzer MP, Zacher M, Pui CH, Hudson MM. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J Clin Oncol. 2007;25:11833–1187.
    1. Dalton VK, Rue M, Silverman LB, Gelber RD, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Tarbell NJ, Sallan SE, Cohen LE. Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment. J Clin Oncol. 2003;21:2953–2960. doi: 10.1200/JCO.2003.03.068.
    1. Breene RAL, Williams RM, Hartle J, Gattens M, Acerini CL, Murray MJ. Auxological changes in UK survivors of childhood acute lymphoblastic leukemia treated without cranial irradiation. Br J Cancer. 2011;104:746–747. doi: 10.1038/bjc.2011.16.
    1. Siviero-Miachon AA, Spinola-Castro AM, Guerra-Junior G. Adiposity in childhood cancer survivors: insights into obesity physiopathology. Arq Bras Endocrinol Metab. 2009;53(2):190–200.
    1. Talvensaari KK, Lanning M, Tapanainen P, Knip M. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab. 1996;81:3051–3055. doi: 10.1210/jc.81.8.3051.
    1. Birkebaek NH, Fisker S, Clausen N, Tuovinen V, Sindet-Pedersen S, Christiansen JS. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 1998;30:351–356. doi: 10.1002/(SICI)1096-911X(199806)30:6<351::AID-MPO9>;2-D.
    1. Gurney JG, Ness KK, Sibley SD, O'Leary M, Dengel DR, Lee JM, Youngren NM, Glasser SP, Baker KS. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107:1303–12. doi: 10.1002/cncr.22120.
    1. Marky L, Mellander L, Lannering B, Albertsson-Wikland K. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol. 1991;19:258–264. doi: 10.1002/mpo.2950190409.
    1. Davies JH, Evans BA, Jones E, Evans WD, Jenney ME, Gregory JM. Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukaemia without cranial irradiation. Clin Endocrinol (Oxf) 2004;60:358–65. doi: 10.1111/j.1365-2265.2003.01986.x.
    1. Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K, Erdmann GR, Gold S, Heerema NA, Hutchinson RJ, Provisor AJ, Trigg ME. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2003;101:3809–3817. doi: 10.1182/blood-2002-08-2454.
    1. Reilly JJ, Brougham M, Montgomery C, Richardson F, Kelly A, Gibson BE. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2001;86:3742–3745. doi: 10.1210/jc.86.8.3742.
    1. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 2000;35:415–20. doi: 10.1002/1096-911X(20001001)35:4<415::AID-MPO4>;2-9.
    1. van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, van der Sluis IM, Krenning EP, Pieters R, van den Heuvel-Eibrink MM. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2006;46:88–93. doi: 10.1002/pbc.20437.
    1. Groot-Loonen JJ, Otten BJ, van't Hof MA, Lippens RJ, Stoelinga GB. Influence of treatment modalities on body weight in acute lymphoblastic leukemia. Med Pediatr Oncol. 1996;27(2):92–97. doi: 10.1002/(SICI)1096-911X(199608)27:2<92::AID-MPO5>;2-O.
    1. Rolland-Cachera MF, Sempe M, Guillard-Bataille M. Adiposity rebound in children: a simple indicator for predicting obesity. Am J Clin Nutr. 1984;34:129–135.
    1. Williams SM, Goulding A. Patterns of growth associated with the timing of adiposity rebound. Obesity. 2008;17:335–341.
    1. Dorosty AR, Emmett PM, Cowin IS, Reilly JJ. Factors associated with early adiposity rebound. Pediatrics. 2000;105:1115–1118. doi: 10.1542/peds.105.5.1115.
    1. Reilly JJ, Kelly A, Ness P, Dorosty AR, Wallace WHB, Gibson BE, Emmett PM. ALSPAC Study Team. Premature adiposity rebound in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2001;86:2775–2778. doi: 10.1210/jc.86.6.2775.
    1. Bray GA, York DA. Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab. 1997;82:2771–2776. doi: 10.1210/jc.82.9.2771.
    1. Wallace AM, Tucker P, Williams DM, Hughes IA, Ahmed SF. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 2003;58:770–6. doi: 10.1046/j.1365-2265.2003.01790.x.
    1. Brennan BM, Rahim A, Blum FW, Adams JA, Eden OB, Shalet SM. Hyperleptinemia in youngs adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? Clin Endocrinol. 1999;50:163–169. doi: 10.1046/j.1365-2265.1999.00622.x.
    1. Skoczen S, Tomasik P, Bik-Multanowski M, Surmiak M, Balwierz W, Pietrzyk JJ, Sztefko K, Gozdzik J, Galicka-Latala D, Strojny W. Plasma levels of leptin and soluble leptin receptor and polymorphisms of leptin gene -18G > A and leptin receptor genes K109R and Q223R, in survivors of childhood acute lymphoblastic leukemia. J Exp Clin Cancer Res. 2011;30:64–73. doi: 10.1186/1756-9966-30-64.
    1. Karaman S, Ercan O, Yildiz I, Bolayirli M, Celkan T, Apak H, Ozkan A, Onal H, Canbolat A. Late effects of childhood ALL treatment on body mass index and serum leptin levels. J Pediatr Endocrinol Metab. 2010;23(7):669–74. doi: 10.1515/JPEM.2010.23.7.669.
    1. Bulow B, Link K, Ahren B, Wilsson AS, Erfwth EM. Survivors of childhood acute lymphoblastic leukemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment. Clin Endocrinol (Oxf) 2004;61:683–691. doi: 10.1111/j.1365-2265.2004.02149.x.
    1. Ross JA, Oeffinger KO, Davies SM, Mertens AC, Langer EK, Kiffmeyer WR, Sklar CA, Stovall M, Yasui Y, Robison LL. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the childhhod cancer survivor study. J Clin Oncol. 2004;22:3558–3562. doi: 10.1200/JCO.2004.11.152.
    1. Schell MJ, Ochs JJ, Schriock EA, Carter M. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 1992;10(1):128–133.
    1. Meacham LR, Gurney JG, Mertens AC, Ness KK, Sklar CA, Robison LL, Oeffinger KC. Body mass index in long-term adult survivors of childhood cancer. A report of the childhood cancer survivor study. Cancer. 2005;103:1730–1739. doi: 10.1002/cncr.20960.
    1. Shaw MP, Bath LE, Duff J, Kelnar CJ, Wallace WH. Obesity in leukemia survivors: the familial contribution. Pediatr Hematol Oncol. 2000;17(3):231–7. doi: 10.1080/088800100276406.
    1. Freedman DS, Serdula MK, Srinavasan SR, Berenson GS. Relation of circumferences and skinfold thickness to lipid in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr. 1999;69:308–317.
    1. Kavey REW, Allada V, Daniels ST, Hayman LL, McCrindle BW, Newburger JW, Parekh RS, Steinberger J. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation. 2006;114:2710–2738. doi: 10.1161/CIRCULATIONAHA.106.179568.
    1. Oeffinger KC, Buchanan GR, Eshelman DA, Denke MA, Andrews TC, Germak JA, Tomlinson GE, Snell LE, Foster BM. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2001;23:424–430. doi: 10.1097/00043426-200110000-00007.
    1. Siviero-Miachon AA, Spinola-castro AM, Guerra-Junior G. Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease. Vasc Health Risk Manag. 2008;4(4):825–836.
    1. Kourti M, Tragiannidis A, Makedou A, Papageorgiou T, Rousso I, Athanassiadou F. Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J Pediatr Hematol Oncol. 2005;27:499–501. doi: 10.1097/01.mph.0000181428.63552.e9.
    1. Chow EJ, Pihoker C, Hunt K, Wilkinson K, Friedman DL. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer. 2007;110:2313–2320. doi: 10.1002/cncr.23050.
    1. Janiszewski PM, Oeffinger KC, Church TS, Dunn AL, Eshelman DA, Victor RG, Brooks S, Turoff AJ, Sinclair E, Murray JC, Bashore L, Ross R. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2007;92(10):3816–21. doi: 10.1210/jc.2006-2178.
    1. Trimis G, Moschovi M, Papassotiriou I, Chrousos G, Tzortzatou-Stathopoulou F. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol. 2007;29(5):309–14. doi: 10.1097/MPH.0b013e318059c249.
    1. Butturini AM, Dorey FJ, Lange BJ, Henry DW, Gaynon PS, Fu C, Franklin J, Siegel SE, Seibel NL, Rogers PC, Sather H, Trigg M, Bleyer WA, Carroll WL. Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2007;25:2063–2069. doi: 10.1200/JCO.2006.07.7792.
    1. Rogers PC, Meacham LR, Oeffinger KC, Henry DW, Lange BJ. Obesity in pediatric oncology. Pediatr Blood Cancer. 2005;45(7):881–91. doi: 10.1002/pbc.20451.
    1. World Cancer Research Fund and American Institute for Cancer Research Global Network.
    1. Reilly JJ, Ventham JC. Risk factors for excess weight gain in children treated for acute lymphoblastic leukemia. Int J Obes Relat Metab Disord. 2000;24:1537–41. doi: 10.1038/sj.ijo.0801403.
    1. Mayer EI, Reuter M, Dopfer RE, Ranke MB. Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm Res. 2000;53(4):193–9. doi: 10.1159/000023566.
    1. Asner S, Ammann RA, Ozshahin H, Beck-Popovic M, von der Weid NX. Obesity in long-term survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51:112–118.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する